Optimizing Chemotherapy for Frail and Elderly Patients With Advanced Gastroesophageal Cancer

Optimizing Chemotherapy for Frail and Elderly Patients With Advanced Gastroesophageal Cancer

>>OK, so we’re talking about gastroesophageal cancer and a study that ASCO has chosen to highlight. Why are you interested in this study?>>I love this study. A perennial problem in cancer clinical trials is that the people we include in our trials are the fit, healthy triathlete cancer patients, and we leave out the largeRead More Optimizing Chemotherapy for Frail and Elderly Patients With Advanced Gastroesophageal Cancer

Ovarian Cancer Tumor-Stroma Proportion and Resistance to Platinum Chemotherapy

Ovarian Cancer Tumor-Stroma Proportion and Resistance to Platinum Chemotherapy

>>You’re publishing a paper in JAMA Oncology about ovarian cancer and chemotherapy. So tell us about this paper.>>This was a very exciting study, although it was very small, only in 24 patients. But the investigators question whether the tumor-stroma proportion could predict those patients who didn’t respond to chemotherapy. So they divided the patients upRead More Ovarian Cancer Tumor-Stroma Proportion and Resistance to Platinum Chemotherapy